disponibile in formato PDF - Stampa alternativa

BIBLIOGRAFIA
■ Baker, D., Pryce, G., Croxford, J.L., Brown, P., Pertwee, R.G., Makriyannis,
A., Khanolkar, A., Layward, L., Fezza, F., Bisogno, T., Di Marzo, V.,
“Endocannabinoids Control Spasticity in a Multiple Sclerosis Model”, in:
FASEB J, vol. 15, 2001, pp. 300-302.
■ Bifulco, M., Di Marzo, V., “Targeting the Endocannabinoid System in Cancer
Therapy: a Call for Further Research”, in: Nature Medicine, vol. 8 (6), 2002, pp.
547-550.
■ Bird, K.D., Boleyn, T., Chesher, G.B., Jackson, D.M., Starmer, G.A., Teo,
R.K.C., “Inter-cannabinoid and Cannabinoid-ethanol Interactions and their
Effects on Human Performance”, in: Psychopharmacology, vol. 71, 1980, pp.
181-188.
■ British Medical Association Staff, Therapeutic Uses of Cannabis, Gordon &
Breach Science Pub, 1999.
■ Darmani, N.A., “Delta(9)-tetrahydrocannabinol and Synthetic Cannabinoids
Prevent Emesis Produced by the Cannabinoid CB(1) Receptor
Antagonist/inverse Agonist SR 141716A”, in: Neuropsychopharmacology, Feb
24(2), 2001, pp. 198-203.
■ Davies, S.N., Pertwee, R.G., Riedel, G., “Functions of Cannabinoid
Receptors in the Hippocampus”, in: Neuropharmacology, vol. 42, 2002, pp.
993-1007.
■ Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin,
G., Gibson, D., Mandelbaum, A., Etinger, A., Mechoulam, R., “Isolation and
Structure of a Brain Constituent that Binds to the Cannabinoid Receptor”, in:
Science, vol. 258, 1992, pp. 1946-1949.
■ Di Marzo, V., Hill, M.P., Bisogno, T., Crossman, A.R., Brotchie, J.M.,
“Enhanced Levels of Endogenous Cannabinoids in the Globus Pallidus are
Associated with a Reduction in Movement in an Animal Model of Parkinson’s
Disease”, in: FASEB J, vol. 14, 2000, pp. 1432-1438.
■ Di Marzo, V., Goparaju, S.K., Wang, L., Liu, J., Batkai, S., Jarai, Z., Fezza, F.,
Miura, G.I., Palmiter, R.D., Sugiura, T., Kunos, G., “Leptin-regulated
Endocannabinoids are Involved in Maintaining Food Intake”, in: Nature, vol.
410, 2001, pp. 822-825.
■ Di Marzo, V., “‘Endocannabinoids’ and Other Fatty Acid Derivatives with
Cannabimimetic Properties: Biochemistry and Possible Physiopathological
Relevance”, in: Biochim Biophys Acta, vol. 1392, 1998, pp. 153-175.
■ Fezza, F., Bisogno, T., Minassi, A., Appendino, G., Mechoulam, R., Di Marzo,
V., “Noladin Ether, a Putative Novel Endocannabinoid: Inactivation
Mechanisms and a Sensitive Method for its Quantification in Rat Tissues”, in:
FEBS Lett., vol. 513, 2002, pp. 294-298.
58